XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.4
CASH FLOWS STATEMENTS - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Operations        
Net income $ 18,765 $ 15,463 $ 39,270 $ 29,356
Adjustments to reconcile net income to net cash from operations:        
Depreciation, amortization, and other 3,496 2,761 6,708 5,406
Stock-based compensation expense 1,897 1,566 3,599 3,022
Net recognized gains on investments and derivatives (307) (354) (671) (482)
Deferred income taxes 183 (17) (5,787) (28)
Changes in operating assets and liabilities:        
Accounts receivable (5,543) (4,008) 4,943 4,835
Inventories 394 788 (383) (20)
Other current assets 830 730 1,770 676
Other long-term assets (908) (1,499) (1,506) (1,561)
Accounts payable 235 33 (236) 348
Unearned revenue (4,343) (3,227) (7,228) (6,291)
Income taxes (2,057) (2,368) 596 (3,351)
Other current liabilities 1,745 1,755 (2,398) (1,196)
Other long-term liabilities 93 893 343 1,137
Net cash from operations 14,480 12,516 39,020 31,851
Financing        
Repayments of debt 0 (3,250) (4,826) (3,250)
Common stock issued 291 302 903 847
Common stock repurchased (7,433) (6,535) (15,117) (13,278)
Common stock cash dividends paid (4,652) (4,230) (8,858) (8,086)
Other, net (192) 79 (364) (156)
Net cash used in financing (11,986) (13,634) (28,262) (23,923)
Investing        
Additions to property and equipment (5,865) (4,174) (11,675) (9,081)
Acquisition of companies, net of cash acquired, and purchases of intangible and other assets (850) (415) (2,056) (896)
Purchases of investments (2,505) (15,092) (12,814) (29,672)
Maturities of investments 5,253 15,264 14,115 29,530
Sales of investments 2,895 2,421 8,525 4,835
Other, net (89) 327 (506) (1,756)
Net cash used in investing (1,161) (1,669) (4,411) (7,040)
Effect of foreign exchange rates on cash and cash equivalents 106 14 33 (32)
Net change in cash and cash equivalents 1,439 (2,773) 6,380 856
Cash and cash equivalents, beginning of period 19,165 17,205 14,224 13,576
Cash and cash equivalents, end of period $ 20,604 $ 14,432 $ 20,604 $ 14,432